Home Elan reorganises Tysabri revenues
 

Keywords :   


Elan reorganises Tysabri revenues

2013-02-06 10:46:00| Biotech - Topix.net

Biogen Idec is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.25 billion plus future royalties on sales of the drug.

Tags: revenues elan tysabri reorganises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11topps now psa10
27.11 THE ORAL CIGARETTES SUCK MY WORLD
27.11 E
27.113DS .SD()
27.11181
27.11YAMAHA KUSHITANI LL
27.11tsnomi.com
27.11
More »